Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)
Clinical trial NCT02870348 · COMPLETED
Trial details
- NCT number
- NCT02870348
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-29
- Primary completion
- 2021-02-16
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.